Skip to content
Brand AI

Angelini

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    Angelini announces acquisition of Arvelle Therapeutics

    Angelini said it would acquire Arvelle Therapeutics in an all-cash transaction valuing the biopharmaceutical company at up to $960 million. The deal would give Angelini Pharma exclusive commercial rights to Arvelle's epilepsy treatment cenobamate in the EU, the UK and Switzerland.

    Source